Patents by Inventor Cathy Quemener

Cathy Quemener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activity
    Patent number: 8940702
    Abstract: The present invention pertains to PF4 muteins which comprise a substitution at position 67, e.g. a L67H substitution, compared to the sequence of the wild-type PF4 protein. Such PF4 muteins exhibit an increased anti-angiogenie activity and a reduced affinity for proteoglycans compared to the wild-type PF4 protein.
    Type: Grant
    Filed: July 26, 2010
    Date of Patent: January 27, 2015
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Bordeaux
    Inventors: Andreas Bikfalvi, Herve Prats, Cathy Quemener, Alexandre Dubrac
  • MUTANTS PF4 POLYPEPTIDES EXHIBITING AN INCREASED ANTI-ANGIOGENIC ACTIVITY
    Publication number: 20120157384
    Abstract: The present invention pertains to PF4 muteins which comprise a substitution at position 67, e.g. a L67H substitution, compared to the sequence of the wild-type PF4 protein. Such PF4 muteins exhibit an increased anti-angiogenie activity and a reduced affinity for proteoglycans compared to the wild-type PF4 protein.
    Type: Application
    Filed: July 26, 2010
    Publication date: June 21, 2012
    Inventors: Andreas Bikfalvi, Herve Prats, Cathy Quemener, Alexandre Dubrac